Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.

Immunity against shigellosis has been shown to correlate with the presence of antibodies specific for Shigella lipopolysaccharide (LPS). We here propose a new candidate vaccine for shigellosis composed of purified Shigella flexneri 2a or Shigella sonnei LPS hydrophobically complexed with group C typ...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Infect Immun
Päätekijät:	Orr, N, Robin, G, Cohen, D, Arnon, R, Lowell, G H
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1993
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC280860/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8500877/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.61.6.2390-2395.1993
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!